Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of Covid-19 Publisher Pubmed



Shahrbaf MA1 ; Tabary M2 ; Khaheshi I1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Cardiovascular and Hematological Disorders - Drug Targets Published:2021


Abstract

After the outbreak of COVID-19, many novel drugs have been introduced to improve pa-tients’ conditions. Remdesivir and Favipiravir are among the most common drugs used against SARS-CoV-2. Although promising, cardiovascular side effects of these drugs should be considered by physicians and nurses. In this study, we searched databases for assessing the cardiovascular side effects of Remdesivir and Favipiravir. It seems that despite the beneficial effects of these drugs, due to the cardiovascular complications of COVID-19 and cardiovascular side effects of these drugs, which can overlap with each other, the use of these drugs can be a challenging issue in the cardiovascular practice. © 2021 Bentham Science Publishers.
Related Docs
View other Related Docs
1. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
2. Investigation of Effective Drugs in the Treatment of Patients With Covid-19, Journal of Iranian Medical Council (2023)
3. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
4. Nanotheranostics Against Covid-19: From Multivalent to Immune-Targeted Materials, Journal of Controlled Release (2020)
5. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
6. Efficacy and Safety of Sofosbuvir/ Ledipasvir in Treatment of Patients With Covid-19; a Randomized Clinical Trial, Acta Biomedica (2020)
7. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
8. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
Experts (# of related papers)
View all Related Experts
Hossein Khalili (2)
Sirous Jafari (2)
Other Related Docs
9. Sofosbuvir and Daclatasvir for the Treatment of Covid-19 Outpatients: A Double-Blind, Randomized Controlled Trial, Journal of Antimicrobial Chemotherapy (2021)
10. Safety and Effectiveness of Favipiravir for Novel Coronavirus (Covid-19): A Rapid Review of Available Evidence, Health Technology Assessment in Action (2020)
11. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
12. Nanomedicine “New Food for an Old Mouth”: Novel Approaches for the Treatment of Covid-19, Drug Delivery Letters (2023)
13. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
14. Interferon Therapy in Patients With Sars, Mers, and Covid-19: A Systematic Review and Meta-Analysis of Clinical Studies, European Journal of Pharmacology (2021)
15. Remdesivir Administration in Covid-19 Patients With Renal Impairment: A Systematic Review, American Journal of Therapeutics (2022)
16. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
17. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)
18. The Efficacy of Remdesivir in Coronavirus Disease 2019 (Covid-19): A Systematic Review, Iranian Journal of Microbiology (2020)
19. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
20. Comparison of the Eight Different Treatment Regimens for the Hospitalized Patients With Covid-19: A Retrospective Cohort Study, Journal of Cellular and Molecular Anesthesia (2021)
21. Safety and Efficacy of Remdesivir for the Treatment of Covid-19: A Rapid Review of Available Evidence, Health Technology Assessment in Action (2020)
22. How to Overcome Cardiovascular Challenges in Covid-19 Patients: A Guide for Common Practice, Acta Biomedica (2020)
23. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)